Skip to content
Screener

Gyre Therapeutics, Inc. GYRE Gyre Pharmaceuticals — Sales & Marketing

Other segment segments

Gyre
$0

Similar metrics at other companies

SharkNinja logo
SNSales & Marketing
$441.51M+23.4%
Taboola.com Ltd. logo
TBLASales & Marketing
$67.16M-5.7%
Dynatrace logo
DTSales & Marketing
$181.63M+9.9%
Clear Secure logo
YOUSales & Marketing
$17.15M+18.4%
OrthoPediatrics logo
KIDSSales & Marketing
$21.29M+11.5%
Zeta Global Holdings logo
ZETASales & Marketing
$104.04M+20.4%

Other financials

Income statement

See full
Revenue$29.1M-2.1%
Gross profit$26.9M-5.9%
Operating income-$14.4M-541%
Net income-$11.7M-471%
EPS (diluted)-$0.12-300%

Balance sheet

See full
Cash & equivalents$43.3M+18.6%
Total debt$3.4M+145%
Total equity$107.9M+17.3%
Total assets$199.3M+30.5%

Cash flow

See full
Operating cash flow-$16.7M-124%
CapEx$262.0K-21.8%
Free cash flow-$17.0M-118%

Valuation

See full
Market cap$712.55M+11.2%
Enterprise value$672.68M+11.0%
P/S-0.1×

Profitability

See full
Gross margin94.3%-1.7pp
Operating margin-14%-18.7pp
Net margin-13.4%-15.1pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-16%-18.3pp
Debt / equity0.0×
Current ratio4.3×-1.1×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-340448
Line itemGyre PharmaceuticalsGyreTotal
Revenues$29,097$8$29,105
Operating expenses
Cost of revenues2,2092,209
Selling and marketing13,75413,754
Research and development9,6974,60314,300
Research and development - related parties4,8364,836
General and administrative4,2683,5947,862
Transaction costs502502

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Gyre Therapeutics, Inc.'s gyre pharmaceuticals — sales & marketing?
Gyre Therapeutics, Inc. (GYRE) reported gyre pharmaceuticals — sales & marketing of $13.75M in Q2 2026.
How has Gyre Therapeutics, Inc.'s gyre pharmaceuticals — sales & marketing changed year-over-year?
Gyre Therapeutics, Inc.'s gyre pharmaceuticals — sales & marketing decreased by 9.5% year-over-year, from $15.2M to $13.75M.
What is the long-term trend for Gyre Therapeutics, Inc.'s gyre pharmaceuticals — sales & marketing?
Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gyre pharmaceuticals — sales & marketing has grown at a 3.2% compound annual growth rate (CAGR), from $61.16M to $65.18M.
What does gyre pharmaceuticals — sales & marketing mean?
This encompasses the costs associated with promoting, advertising, and distributing the segment's pharmaceutical products to healthcare providers and patients. It provides insight into the company's investment in commercial infrastructure and market penetration efforts.

Ask your AI about Gyre Therapeutics, Inc.'s gyre pharmaceuticals — sales & marketing.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude